What happened Shares of GW Pharmaceuticals (NASDAQ: GWPH) were skyrocketing 46.3% as of 10:45 a.m. EST on Wednesday. The huge gain came after Jazz Pharmaceuticals (NASDAQ: JAZZ) announced plans to acquire GW for $7.2 billion.
Full Answer
Who sold GW Pharmaceuticals Company stock in the last year?
Company insiders that have sold GW Pharmaceuticals company stock in the last year include Adam D George, Cabot Brown, Christopher J Tovey, Douglas B Snyder, Geoffrey W Dr Guy, Justin D Gover, and Volker Knappertz. View insider buying and selling activity for GW Pharmaceuticals or view top insider-selling stocks.
Is GW Pharmaceuticals'revenue Trending up or down?
Over the last half decade GW Pharmaceuticals's revenue has actually been trending down at about 20% per year. On the other hand, the share price done the opposite, gaining 22%, compound, each year. It just goes to show tht the market is forward looking, and it's not always easy to predict the future based on past trends.
How did GW Pharmaceuticals'Epidiolex make money last year?
It was approved by the Food and Drug Administration in 2018 to treat seizures resulting from early-onset epilepsy. Last year, Epidiolex brought in $510.5 million in sales, up 70% over 2019, making up nearly all of GW's $527.2 million in revenue for the year.
How many times has the Fool written about GW Pharmaceuticals?
The Fool has written over 500 articles on GW Pharmaceuticals. All Market Moves Podcasts Earnings GW Pharmaceuticals Stockholders Approve Acquisition by Jazz Pharmaceuticals
What happened to my GW Pharmaceuticals?
Jazz Pharmaceuticals (NASDAQ:JAZZ) has officially closed its $7.2B acquisition of GW Pharmaceuticals plc (NASDAQ:GWPH). GW shareholders gave the thumbs up to the deal last month. With the acquisition, Jazz gains access to GW's cannabinoid portfolio, including Epidiolex, which raked in $510.5M in sales in 2020.
Does GW Pharmaceuticals still exist?
In May 2013, the company became dual-listed on the NASDAQ and AIM. In 2014, the company made a deal with New York to develop clinical trials using cannabidiol (CBD) to treat children who suffer from seizures and other medical complications. In May 2021, Jazz Pharmaceuticals acquired the company.
Did GW Pharmaceuticals stock split?
GWPH Stock Flies On Takeover Deal Under the terms of the deal, Jazz will pay $220 per American depositary share. That's split in $200 per ADS in cash and $20 in Jazz ordinary shares. The entire deal values GWPH stock at $7.2 billion, or $6.7 billion net of GW Pharma's cash.
Who bought out GW Pharmaceuticals?
Jazz PharmaceuticalsA big merger at the intersection of the marijuana and pharmaceutical industries is one step closer to completion. On Friday, shareholders of GW Pharmaceuticals (GWPH) approved its acquisition by a subsidiary of Jazz Pharmaceuticals (JAZZ -1.92%), both companies announced in a joint press release.
Is GW Pharmaceuticals publicly traded?
GW Leads the Pack Another top performing publicly traded cannabis company was GW Pharmaceuticals, which was acquired by Jazz Pharmaceuticals (Nasdaq: JAZZ) for $225 per share earlier this year.
How much did GW Pharmaceuticals sell for?
$7.2 billionJazz Pharmaceuticals paying $7.2 billion for cannabis drug maker GW Pharma has investors looking at early-stage psychedelic companies. Tryp Therapeutics is one of only a handful of companies moving into Phase 2 clinical trials with a psychedelic compound.
How much did jazz Buy GW for?
$7.6 billionJazz Pharmaceuticals (JAZZ -1.42%) and GW Pharmaceuticals are now under the same corporate roof. The two companies announced Wednesday that Jazz's acquisition of GW has been completed. This brings the $7.6 billion cash-and-stock deal, first announced in early February, to a close.
Is GWPH a buy or sell?
The VGM score is based on the trading styles of Growth, VAlue, and Momentum....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy25.08%2Buy18.56%3Hold10.15%4Sell5.79%2 more rows
What company owns Epidiolex?
GW is known for its FDA-approved cannabinoid therapy for treating certain forms of epilepsy (Epidiolex). Canopy Growth owns U.S. Patent No.
How do I buy GW pharmaceutical stock?
How to buy shares in GW PharmaceuticalsCompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
Is Jazz Pharmaceuticals an acquisition target?
Corinne Cardina: Another deal that was more recently announced just this week, Jazz Pharmaceuticals announced that they were going to be acquiring GW Pharmaceuticals. That is the British company that has the only FDA-approved CBD derived drug, Epidiolex. Jazz may be a new name for pot investors.
How were GW Pharmaceuticals' earnings last quarter?
GW Pharmaceuticals plc (NASDAQ:GWPH) released its quarterly earnings data on Tuesday, November, 3rd. The biopharmaceutical company reported ($0.36)...
Who are GW Pharmaceuticals' key executives?
GW Pharmaceuticals' management team includes the following people: Mr. Justin D. Gover , CEO & Exec. Director (Age 50, Pay $1.19M) ( LinkedIn Pr...
What is Justin Gover's approval rating as GW Pharmaceuticals' CEO?
14 employees have rated GW Pharmaceuticals CEO Justin Gover on Glassdoor.com . Justin Gover has an approval rating of 80% among GW Pharmaceuticals...
Who are some of GW Pharmaceuticals' key competitors?
Some companies that are related to GW Pharmaceuticals include Royalty Pharma (RPRX) , MERCK Kommanditgesellschaft auf Aktien (MKGAF) , Takeda Ph...
What other stocks do shareholders of GW Pharmaceuticals own?
Based on aggregate information from My MarketBeat watchlists, some companies that other GW Pharmaceuticals investors own include (CGC) , NVIDIA...
What is GW Pharmaceuticals' stock symbol?
GW Pharmaceuticals trades on the NASDAQ under the ticker symbol "GWPH."
What is GW Pharmaceuticals' stock price today?
One share of GWPH stock can currently be purchased for approximately $218.96.
How much money does GW Pharmaceuticals make?
GW Pharmaceuticals has a market capitalization of $6.86 billion and generates $311.33 million in revenue each year. The biopharmaceutical company e...
How many employees does GW Pharmaceuticals have?
GW Pharmaceuticals employs 1,161 workers across the globe.